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Abstract
Introduction: The incidence of multiple primary cancers is reported to be between 0.3% and 4.3%. The second 
primary lesion is identified either simultaneously with the primary lesion (synchronous) or after a period of time 
(metachronous). Few cases of metastasis of breast carcinoma to the esophagus and vice versa have been reported in 
the past.
Case presentation: We report an extremely rare case of a 55-year-old Indian woman who had carcinomas in both the 
esophagus and the breast simultaneously. She was treated successfully using combined modalities of surgery, 
chemotherapy and radiation therapy.
Conclusion: Cases of synchronous double malignancies can be treated by dealing with the malignancy in the two 
sites as independent carcinomas. We have to take into consideration the total dose of radiation to a critical organ as 
well as the effect of the total dose of toxic chemotherapeutic drugs on our patient.
Introduction
The incidence of double malignancy is very low, as is a
case of synchronous breast and esophageal carcinomas.
Double malignancy cases pose the problem of finding the
best treatment for the patient. We present such a case
which was treated successfully.
Case presentation
A 55-year-old Indian woman reported to the hospital
with complaints of dysphagia for solid foods for more
than one year which had progressively increased in sever-
ity. At presentation, she had also developed difficulty in
swallowing liquids and had a history of regurgitation of
food after meals. There was no history of cough or diffi-
culty in breathing during meals, thus ruling out the possi-
bility of a tracheoesophageal fistula.
A thorough physical examination revealed a lump in
the left breast of approximately 3 × 3 cm in size. The
lump was hard in consistency with irregular margins, and
it was not fixed to the skin or to underlying structures.
Two firm, mobile ipsilateral axillary lymph nodes with
mild tenderness could be palpated. Our patient did not
have any family history of breast or ovarian carcinoma.
She had breastfed all three of her children and had been
postmenopausal for eight years. There was also no his-
tory of oral contraceptive pills or hormone replacement
therapy.
Upper gastrointestinal endoscopy revealed a friable,
ulceronodular lesion at the gastroesophageal junction
involving the juxta-esophageal fundus. Endoscopic
biopsy of the lesion was carried out. Histopathological
examination of the biopsy tissue showed moderately dif-
f e r e n t i a t e d  s q u a m o u s  c e l l  c a r c i n o m a .  A  c o m p u t e d
tomography (CT) scan of our patient's thorax and abdo-
men showed a soft tissue density space-occupying lesion
in the distal esophagus and cardiac end of her stomach.
The lesion was characterized as an irregular thickening of
the wall with a widened lumen. The length of involve-
ment was approximately 6 cm.
There was no proximal dilation of the esophagus. Evi-
dence of aspiration was seen in the right basal segment of
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her lung. No atelectasis or pneumanitic lung tissue was
seen. Significantly sized bronchopulmonary lymphade-
nopathy was seen bilaterally.. Anterior and superior
mediastinal facial planes were preserved. No significant
anteroposterior or superior-mediastinal lymph nodes
were found. No pleural collection of fluid was seen. An
increased attenuating lesion was seen in the left breast
superior to the nipple, measuring approximately 24 mm
in diameter. The margins of this lesion were not sharply
defined, and no calcification was seen. No other lesions
were found. Her liver was mildly enlarged with no focal
lesions and a normal portal venous system and intra-
hepatic biliary radicles. The porta hepatis was also free of
lymph nodes.
Significant lymphadenopathy was seen along the celiac
trunk and the lesser curvature of the stomach along the
gastric artery. The para-aortic and para-caval regions
were normal. The splenic hilum was also free of lymph
nodes. All other findings were within normal limits.
Fine needle aspiration cytology from the lump of the
left breast suggested an infiltrating ductal carcinoma. In
view of our findings, a transhiatal esophagogastrectomy
and a left-sided modified radical mastectomy with axil-
lary dissection were carried out. Ten centimeters of the
esophagus as well as 5 cm along the lesser and 3 cm along
the greater curvature of the proximal stomach were
removed. Grossly, the tumor involved the adventitia of the
lower end of the esophagus and also the pericardial fat.
Microscopic analysis showed moderately differentiated
squamous cell carcinoma type with a predominantly
pseudo glandular pattern, involving the lower third of the
esophagus, the cardioesophageal junction and the cardiac
end of the stomach (Figure 1). The tumor had invaded the
muscular layer of the esophagus and extended to the
adventitia. Perineural infiltration and lymphatic emboli
were noted. Circumferential cut margins were free of
tumor. The tumor had infiltrated the full thickness of the
wall of the cardia of the stomach and had invaded the
peri-gastric fat. Seven out of nine nodes along the lesser
curvature showed metastasis with perinodal extension.
One node along the greater curvature showed metastasis
with perinodal extension. Esophageal cut margin and gas-
tric cut margin were free of tumor.
Histopathological analysis of the left modified radical
mastectomy revealed the tumor to be an infiltrating duc-
tal carcinoma grade II (Figure 2). A comedo-type of duc-
tal carcinoma in situ of nuclear grade II was noted within
the same tumor, the content of which was not clinically
significant. Areas of necrosis and tumor calcification
were noted. No perineural infiltration and lymphovascu-
lar emboli were found.
The nipple, areola, skin and base were free of tumor. All
the 14 lymph nodes we dissected were reactive. Immuno-
histochemistry of the operative specimens was per-
formed. The breast tumor was negative for estrogen and
progesterone receptors, but was positive for human epi-
dermal growth factor receptor 2 (HER-2 neu).
Three months after surgery, our patient complained of
dysphagia. A CT scan revealed a recurrence of the carci-
noma in her esophagus (Figure 3). Our patient had
received four cycles of docetaxel and Adriamycin (doxo-
rubicin)-based chemotherapy before the recurrence of
the esophageal growth. As our patient was HER-2neu
positive, a taxane-based regimen was planned, consider-
ing that the single agent docetaxel has previously been
effective in treating esophageal carcinomas. Our patient
was not prescribed Herceptin (trastuzumab) as she could
not afford the drug. Instead, she was treated with locore-
gional radiation therapy for the recurrence of the carci-
Figure 1 Histopathology of esophageal growth. Photomicrograph 
of histopathological analysis of esophageal growth showing moder-
ately differentiated squamous cell carcinoma type with a predomi-
nantly pseudo-glandular pattern.
Figure 2 Histopathology of breast lesion. Photomicrograph of his-
topathological analysis of left modified radical mastectomy specimen 
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noma in her esophagus, taking care with the dosage
delivered to the heart. She was given a total dose of 65Gy
in 32 fractions over seven weeks. Initially, 40Gy was given
by anterioposterior-posterioanterior fields. The remain-
ing dose was delivered by three oblique fields. The
remaining two cycles of chemotherapy were given after
completion of the radiation treatment. Our patient is cur-
rently symptom-free and doing well one year and eight
months after completion of the treatment. She had fol-
low-up clinical examination monthly for one year. An
upper gastrointestinal endoscopy and a CT scan of her
thorax were performed every three months. Currently,
our patient has follow-up appointments every two
months and is advised to have six-monthly investigations.
Discussion
The incidence of multiple primary cancers is rare and is
reported to be between 0.3% and 4.3%. The second pri-
mary lesion is identified either simultaneously with the
primary lesion (synchronous) or after a period of time
(metachronous). The association between synchronous
primary tumors in the aerodigestive tract is a well-known
phenomenon that has been explained by the concept of
"field cancerization " [1]. The mucous epithelium of the
head and neck, lung and esophagus is exposed to com-
mon carcinogenic agents, leading to multiple carcinomas
in these regions. Strong epidemiological evidence impli-
cates tobacco as the main carcinogen and alcohol as a
promoter of carcinogenesis. The incidence of synchro-
nous cancers in patients with esophageal cancer ranges
from 3.6% to 27.1% [2,3]. Most of these synchronous can-
cers are in the head and neck regions.
Other frequently reported sites of synchronous cancer
associated with esophageal cancer are the stomach, lung
and urinary bladder [4,5]. Although numerous epidemio-
logical studies over more than five decades have pointed
to drinking and smoking as possible causes of this phe-
nomenon [2-4], the reason why some patients are partic-
ularly likely to develop multiple cancers remains obscure.
Cases of malignancy of the breast with synchronous or
metachronous malignancies of the ovary, stomach, rec-
tum and oral cavity have been reported. Studies have
shown the association of both adenocarcinoma and
squamous cell carcinoma of the esophagus with carci-
noma of the breast [6]. There have also been some
reports of carcinoma of the esophagus in women who
were treated successfully for carcinoma of the breast, but
none of the cases reported had both malignancies simul-
taneously. Besides these, there have been few case reports
of metastasis of breast carcinoma to the esophagus or
vice versa.
No other cases of synchronous double malignancy of
breast and esophageal carcinomas can be found. Breast
carcinoma represents one of the most common origins of
metastasis to the esophagus [7]. The common sites of
metastasis from breast carcinoma include local and dis-
tant lymph nodes, lung parenchyma, bones, liver and
brain. Though less common, gastrointestinal carcinomas
involving everything from the tip of the tongue to the rec-
t u m ,  s e c o n d a r y  t o  m e t a s t a t i c  b r e a s t  c a r c i n o m a ,  h a v e
been reported. Most of these lesions occur years after
treatment of the primary breast cancer and can be con-
fused with a second primary. There have also been
reports of esophageal carcinoma developing after radia-
tion treatment to the primary breast carcinoma. Here, we
report an extremely rare case of a patient having carci-
noma of the esophagus and the breast at the same time.
In this case, the histopathology of the breast tumor was
an infiltrating ductal carcinoma grade II and the histopa-
thology of the esophageal growth was a moderately dif-
ferentiated squamous cell carcinoma type, ruling out any
possibility of metastasis from any one site to the other.
Resection of both neoplasms frequently offers the best
chance of long-term survival. However, even in the case
of an incurable synchronous cancer (e.g. metastatic pros-
tate cancer), esophagectomy is not always contraindi-
cated [8]. The type of treatment for such esophageal
carcinomas strongly depends on the type and prognosis
of the synchronous malignancy. Evidence-based argu-
Figure 3 Computed tomography of thorax showing recurrence 
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ments about whether to perform a simultaneous or a
staged operation are not available. Studies report that
simultaneous resection of both neoplasms has acceptably
low morbidity and mortality rates [9]. However, for each
patient, the risks and benefits of simultaneous surgery
should be weighed against those of a staged surgery [10].
Our patient underwent surgery for both the primaries
because her general condition was good and she had no
other medical reasons to deny surgery. However, the
choice of chemotherapy was a difficult task. She was
given four cycles of Adriamycin (doxorubicin) and doc-
etaxel-based chemotherapy given that HER-2/neu posi-
tive breast carcinomas respond better to taxane-based
chemotherapy and docetaxel is effective as a single agent
treatment for esophageal carcinoma. Radiation therapy
was given to treat a recurrence in our patient's esophagus.
Two more cycles were administered after the completion
of radiation treatment. Studies of multiple primary malig-
nancies have been useful tools for exploring risk factors
by examining associations between different malignan-
cies. An association between two cancers might suggest
that those cancers share etiological risk factors. Three
tumor suppressor genes common to breast and esopha-
geal carcinomas are p53, Rb and p16 genes. Two risk fac-
tors that are common to these two carcinomas are
alcohol intake and obesity.
Positive association between alcohol intake and carci-
noma of the breast has been consistently demonstrated.
The risk appears to be linearly related to the amount of
alcohol consumed. Alcohol intake and tobacco use are
considered to be the major contributory factors in the
development of esophageal carcinoma worldwide. It is
estima t ed t ha t 90% of squamous ce ll car cinoma of the
esophagus in western Europe and North America can be
attributed to tobacco and alcohol use.
About 25% of breast carcinomas worldwide are due to
obesity, according to the international agency for
research on cancer. The literature indicates that increased
body mass index (BMI) is a risk factor for adenocarci-
noma of the esophagus and that individuals with the
highest BMI have up to a seven-fold greater risk of esoph-
ageal carcinoma than those with a low BMI. Other possi-
ble explanations for such an association would be a
hereditary predisposition to multiple cancers, as side
effect of previous treatment for cancer, or to a chance
phenomenon. Further studies are needed to guide the
treatment of such cases.
Conclusions
The incidence of multiple primary cancers is rare. The rea-
son why some patients are more prone to develop multiple
cancers remains obscure. Synchronous double malignan-
cies can be treated by considering the malignancy at two
separate sites as independent carcinomas, taking in con-
sideration the total dose of radiation to a critical organ
and the total dose of toxic chemotherapeutic drugs.
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